Sentences with phrase «ischemic mitral»

This study was presented at the Featured Clinical Research Session I: Two - year Outcomes of Surgical Treatment of Moderate Ischemic Mitral Regurgitation: A Randomized Clinical Trial from The Cardiothoracic Surgical Trials Network The Moderate Ischemic Mitral Regurgitation trial was supported by a cooperative agreement (U01 HL088942) funded by the National Heart Lung and Blood Institute, the National Institutes of Neurological Disorders and Stroke of the National Institutes of Health (NIH), Bethesda, MD, and the Canadian Institutes of Health Research.

This study was presented as the Late - Breaking Clinical Trial (Abstract 49403): The Surgical Treatment of Moderate Ischemic Mitral Regurgitation: A Randomized Clinical Trial From The Cardiothoracic Surgical Trials Network.

Because most patients with ischemic mitral regurgitation have multivessel coronary artery disease requiring revascularization, surgeons have to consider whether to add mitral - valve repair to coronary - artery bypass grafting (CABG).

Ischemic mitral regurgitation of moderate severity develops in approximately 10 percent of patients after myocardial infarction.

These highly anticipated study findings, Two - Year Outcomes of Surgical Treatment of Moderate Ischemic Mitral Regurgitation, were presented today by Robert Michler, M.D. at the American College of Cardiology Scientific Session 2016 and published simultaneously in the New England Journal of Medicine by the Cardiothoracic Surgical Trials Network (CTSN).

The Cardiothoracic Surgical Trials Network (CTSN) is reporting results for the first time from a clinical trial of patients who have a complication of coronary heart disease known as moderate ischemic mitral regurgitation (IMR).